CCR9 and neoplasm: Notably, recent research indicates that tumor cells can also express CCL25 [41, 42], potentially promoting the infiltration of cytotoxic, CCR9-expressing tumor-infiltrating lymphocytes into the tumor microenvironment, thereby enhancing anticancer effects [43, 44].